Specialty Cardiovascular
-
Featured
New Collaborative Program Improves Marfan Syndrome Outcomes
The Marfan Syndrome and Related Conditions Program at Massachusetts General Hospital delivers comprehensive, lifetime care, including valve-sparing aortic root replacements, to increase life expectancy in patients with Marfan syndrome
-
Featured
Proteomics Profiling Reveals Plasma Biomarkers of Hypertrophic Cardiomyopathy
In the first study of its kind, researchers at Massachusetts General Hospital applied proteomics profiling to reveal plasma protein biomarkers of hypertrophic cardiomyopathy—and found that some of the proteins correlated with known indicators of advanced disease.
-
Leveraging Machine Learning Techniques for Cardiovascular Care
Collin M. Stultz, MD, PhD, cardiologist in the Cardiology Division, discusses applying machine learning techniques to care for patients with cardiovascular disease.
-
Conscious Sedation Confers Better Outcomes vs. General Anesthesia in TAVR
There is a growing interest in the concept of minimalist TAVR, which utilizes conscious sedation rather than general anesthesia for the procedure. This use of conscious sedation has been linked to improved outcomes in mortality, length of stay and discharge to home compared with general anesthesia.
-
POPular TAVI Reveals No Need for Clopidogrel in Afib Patients Undergoing TAVR
The POPular TAVI trial shows that atrial fibrillation patients undergoing TAVR have lower mortality rates and bleed less when administered oral anticoagulation (OAC) alone than in combination with clopidogrel, supporting the current standard of not administering clopidogrel.
-
Cardiac Injury and Cardiovascular Events Are Common After CAR T Therapy
Mass General researchers have reported the first registry data on cardiac toxicities and cardiovascular events among adult patients who received chimeric antigen receptor T-cell therapy.
Cardiovascular contributors
-
Aaron L. Baggish, MD
Director, Cardiovascular Performance Program, Director, Cardiovascular Performance Program Fellowship
Recent Article
Weight Gain in College Football Players Is Mechanism of Subclinical Cardiovascular Pathology
-
Ahmed A. Tawakol, MD
Co-Director, Cardiac MR PET CT Program
Recent Article
Neuroimmune Pathway Linked to Socioeconomic Status and CVD Outcomes -
Ami B. Bhatt, MD
Director, Mass General Adult Congenital Heart Disease Program, Director, Outpatient Cardiology
Recent Article
Cardiovascular Care: The Ideal Model for Telemedicine & Digital Health Care Delivery
-
Anthony Rosenzweig, MD
Chief, Cardiology Division, Co-Director, Corrigan Minehan Heart Center
Recent Article
Medical Grand Rounds: Cardiac Manifestations of COVID-19
-
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Interventional Treatment of Chronic Total Occlusion
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
Jagmeet P. Singh, MD, PhD
Attending Physician, Cardiac Arrhythmia Service, Massachusetts General Hospital
Recent Article
CRT Improves Left Ventricular Function for Chemotherapy-Induced Cardiomyopathy Patients
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Review: Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays
-
Jason H. Wasfy, MD
Medical Director, Massachusetts General Physicians Organization, Director of Quality and Analytics, Massachusetts General Hospital Heart Center
Recent Article
Medical Grand Rounds: Cardiac Manifestations of COVID-19
-
Jennifer E. Ho, MD
Cardiologist, Heart Failure and Transplantation Program, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Men and Women with HFpEF Differ in Physiologic Responses to Exercise
-
Kenneth Rosenfield, MD, MHCDS
Section Head, Vascular Medicine and Intervention, Chairman, STEMI & Acute MI Quality Improvement Committee
Recent Article
Mass General Provides Guidance for Anticoagulation in Patients with COVID-19
-
Nasrien E. Ibrahim, MD
Associate Director, Resynchronization & Advanced Cardiac Therapeutics Program
Recent Article
New AI Model Predicts Acute Kidney Injury After Angiography
-
Steven A. Lubitz, MD, MPH
Cardiac Electrophysiologist
Recent Article
Model Derived from Electronic Health Records System Predicts Risk of Atrial Fibrillation
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Outcomes of Elective Cardiac Surgery at Mass General Not Affected by Start Time
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Co-Director, Cardiac MR PET CT Program
Recent Article
Cardiac Injury and Cardiovascular Events Are Common After CAR T Therapy
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
